[Retracted] The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma

<div>(a) Univariate analysis and (b) multivariate analysis were used to analyze the association of CDCA2 and several clinical features with five-year survivals.</div>

Disease Markers

fig2

Figure 2

Figure 2: [Retracted] The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma 